BioScrip (BIOS) Tops Q4 EPS by 2c, FY Revenue Guidance Comes in Light
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Price: $10.80 --0%
Financial Fact:
Income tax (benefit) expense: 421K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income tax (benefit) expense: 421K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $240.1 million versus the consensus estimate of $235.68 million.
GUIDANCE:
BioScrip sees FY2017 revenue of $920-950 million, versus the consensus of $952 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
